DRMA Stock Price & Quote | Dermata Therapeutics, Inc. Common Stock | FurlPay
Dermata Therapeutics, Inc. Common Stock (DRMA) Stock Price
Dermata Therapeutics, Inc. Common Stock (NASDAQ: DRMA) last traded at $1.42, up 2.90% on the session. The quote above updates while this page is open; the figures below are drawn from Dermata Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Dermata Therapeutics, Inc. Common Stock (DRMA) company overview
Dermata Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DRMA. Its market capitalisation is $5.71 million.
DRMA valuation
Valuation measures for Dermata Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$5.71M
Enterprise value
$3.13M
Price / book
1.64
Beta
1.21
DRMA financials
Trailing-twelve-month figures tagged in Dermata Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$8.37M
Return on equity
-239.95%
Cash
$4.41M
DRMA trading statistics
Range and volume for DRMA over the past 52 weeks.
52-week high
$6.23
52-week low
$0.951
Volume
226.7K
Average volume
737.0K
Previous close
$1.38
Dermata Therapeutics, Inc. Common Stock (DRMA) FAQs
What is the DRMA stock price today?
Dermata Therapeutics, Inc. Common Stock (DRMA) last traded at $1.42, up 2.90% on the session. FurlPay quotes DRMA from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is DRMA listed on?
Dermata Therapeutics, Inc. Common Stock is listed on NASDAQ under the ticker symbol DRMA.
What is Dermata Therapeutics, Inc. Common Stock's market cap?
Dermata Therapeutics, Inc. Common Stock has a market capitalisation of $5.71 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is DRMA's 52-week range?
Over the past 52 weeks DRMA has traded between $0.95 and $6.22.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001853816), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.